1. The State Board of Health shall license amygdalin (laetrile) and procaine hydrochloride with preservatives and stabilizers (Gerovital H3) for manufacture in this state. Such licensing is not a representation that either substance has any therapeutic effect. 2. The Commissioner shall: (a) Adopt regulations which prescribe minimum standards for manufacturers in preparing, compounding, processing and packaging each substance. (b) Make periodic tests and inspections of both the facilities for manufacture and samples of the substances to ascertain the purity, quality and identity of the substance and to determine that the substance meets the standards prescribed pursuant to paragraph (a). (c) Before acting upon an application for a license, collect the fees necessary to pay the cost of investigating the applicant. A license shall not be issued until the applicant has paid all actual costs for the initial testing, inspection, investigation and hearings. 3. The Commissioner may, after notice and hearing, revoke, suspend or refuse to renew the license of any person who: (a) Fails to maintain the standards required by paragraph (b) of subsection 2. (b) Violates any regulation adopted by the Commissioner. (c) Fails to pay any assessment prescribed in paragraph (c) of subsection 2 within a reasonable time. 4. The Attorney General shall, at the request of the Commissioner seek injunctive relief for any violation of the regulations adopted by the Commissioner.
‹ Prev All Nevada sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.